RNA interference treatment in primary hyperoxaluria type 1

被引：0
|
作者：
Monteverde, Marta Lidia [1 ]
机构：
[1] Hosp Juan P Garraham, Jefa Clin, Nefrol, Buenos Aires, Argentina
来源：
REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE | 2023年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [1] Progress with RNA Interference for the Treatment of Primary Hyperoxaluria
    Kathryn Sawyer
    Stephen Leahy
    Kyle D. Wood
    BioDrugs, 2022, 36 : 437 - 441
  • [2] Progress with RNA Interference for the Treatment of Primary Hyperoxaluria
    Sawyer, Kathryn
    Leahy, Stephen
    Wood, Kyle D.
    BIODRUGS, 2022, 36 (04) : 437 - 441
  • [3] RNA Interference (RNAi) Treatment in Patients With Primary Hyperoxaluria Type 1 on Dialysis: How to Prove Treatment Success?
    Higueras, Cristina Martin
    Torres, Armando
    Stefanidis, Constantinos J.
    Beck, Bodo B.
    Hoppe, Bernd
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 695 - 695
  • [4] Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria
    Forbes, Thomas A.
    Brown, Bob D.
    Lai, Chengjung
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2525 - 2538
  • [5] MULTICENTRIC EXPERIENCE WITH RNA INTERFERENCE MEDICATION (OXLUMO®) IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1
    Martin Higueras, Cristina
    Santana Estupinan, Raquel
    Torres Ramirez, Armando
    Stefanidis, Constantinos
    Walli, Adam
    Beck, Bodo B.
    Hoppe, Bernd
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I784 - I784
  • [6] Treatment of primary hyperoxaluria type 1
    Gupta, Asheeta
    Somers, Michael J. G.
    Baum, Michelle A.
    CLINICAL KIDNEY JOURNAL, 2022, 15 (SUPPL 1) : i9 - i13
  • [7] European multicenter experience with RNA interference medication (Oxlumo®) in patients with Primary Hyperoxaluria type 1
    Martin-Higueras, Cristina
    Torres, Armando
    Estupinan, Raquel Santana
    Stefanidis, Constantinos
    Walli, Adam
    Beck, Bodo
    Hoppe, Bernd
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2292 - 2293
  • [8] UTILITY ESTIMATES FOR TREATMENT IN PRIMARY HYPEROXALURIA TYPE 1
    de Freitas, H.
    Hubig, L.
    Lombardelli, S.
    Danese, D.
    Lloyd, A.
    VALUE IN HEALTH, 2022, 25 (07) : S544 - S544
  • [9] RNA INTERFERENCE OF HEPATIC LACTATE DEHYDROGENASE REDUCES URINARY OXALATE IN A MOUSE MODEL OF PRIMARY HYPEROXALURIA TYPE 1
    Wood, Kyle
    Knight, John
    Assimos, Dean
    Holmes, Ross
    JOURNAL OF UROLOGY, 2018, 199 (04): : E73 - E73
  • [10] A new era of treatment for primary hyperoxaluria type 1
    Florian Erger
    Bodo B. Beck
    Nature Reviews Nephrology, 2021, 17 : 573 - 574
12345